S
SBFMW
Sunshine Biopharma Inc
0.0499
0.00000.00%Closed09:30 08/21 EDT
OPEN/PREV CLOSE0.0499/0.0499
TODAY RANGE0.0499-0.0499
VOL2
MARKET CAP--
52 WEEK RANGE0.0160-0.6498
AVG VOL (3M)17.99K
% TURNOVER0%
TURNOVER--
P/E (TTM)-0.0050
% RANGE--
EPS(TTM)-10.0329
P/E(FORWARD)--
P/B0.0043
BVPS11.53
DIVIDEND--
P/S0.0007
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP--
SHARES OUTSTANDING--
NEXT EARNINGS08/11-08/14
FREE FLOAT--
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·3d ago
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug
TipRanks·08/07 13:06
Sunshine Biopharma launches generic amoxicillin formulation in Canada
TipRanks·08/04 13:16
Sunshine announces approval of generic Dienogest tablets for Canadian market
Benzinga·08/04 12:31
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval
TipRanks·08/03 13:19
Sunshine Biopharma Adjusts Series B Warrant Terms
TipRanks·07/28 12:21
Sunshine Biopharma announces approval of generic Ondansetron tablets
Benzinga·07/20 21:05
12 Health Care Stocks Moving In Monday's After-Market Session
TipRanks·07/20 20:48
Sunshine Biopharma Announces ATM Equity Sales Agreement
Benzinga·07/20 20:30
Sunshine Biopharma Inks $4M At-The-Market Sales Agreement With Aegis Capital
TipRanks·07/20 12:45
Sunshine Biopharma announces publication of new results on MR1-114
TipRanks·07/10 21:19
Sunshine Biopharma Settles Dispute With Former Nora President
TipRanks·06/25 12:20
Sunshine Biopharma receives Canadian approval for generic Arimidex
NASDAQ·06/02 12:41
Pre-Market Movers: BJDX, PMI, SBFM Drive Momentum